These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9186269

  • 1. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.
    Fridström M, Sjöblom P, Pousette A, Hillensjö T.
    Eur J Endocrinol; 1997 May; 136(5):488-92. PubMed ID: 9186269
    [Abstract] [Full Text] [Related]

  • 2. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC, Hop WC, de Jong FH, van Dessel TJ, Fauser BC.
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [Abstract] [Full Text] [Related]

  • 3. Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.
    Lanzone A, Fulghesu AM, Spina MA, Apa R, Menini E, Caruso A, Mancuso S.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1253-8. PubMed ID: 3119655
    [Abstract] [Full Text] [Related]

  • 4. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
    Fauser BC, Donderwinkel P, Schoot DC.
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
    [Abstract] [Full Text] [Related]

  • 5. Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome.
    Dale O, Tanbo T, Lunde O, Abyholm T.
    Acta Obstet Gynecol Scand; 1993 Jan; 72(1):43-6. PubMed ID: 8382432
    [Abstract] [Full Text] [Related]

  • 6. What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation.
    Ganor-Paz Y, Friedler-Mashiach Y, Ghetler Y, Hershko-Klement A, Berkovitz A, Gonen O, Shulman A, Wiser A.
    J Endocrinol Invest; 2016 Jul; 39(7):799-803. PubMed ID: 26797707
    [Abstract] [Full Text] [Related]

  • 7. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H, Huang GN, Cao YX, Zhong Y, Huang YH, Zhu GJ, Zhou LM, Chen ZJ, Shi JZ, Zeng Y, Weng N, Huang XF, Yang J, Zhu YM, Li YP, Yi D, Zhuang GL.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [Abstract] [Full Text] [Related]

  • 8. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
    Dale PO, Tanbo T, Haug E, Abyholm T.
    Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
    [Abstract] [Full Text] [Related]

  • 9. [Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome].
    Chen ZJ, Shi YH, Li Y, Gao Q, Sheng Y, Ma ZX.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):571-5. PubMed ID: 19087489
    [Abstract] [Full Text] [Related]

  • 10. Urofollitropin and ovulation induction.
    van Wely M, Yding Andersen C, Bayram N, van der Veen F.
    Treat Endocrinol; 2005 Aug; 4(3):155-65. PubMed ID: 15898821
    [Abstract] [Full Text] [Related]

  • 11. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodríguez Escudero FJ.
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [Abstract] [Full Text] [Related]

  • 12. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations.
    Strowitzki T, Seehaus D, Korell M, Hepp H.
    Exp Clin Endocrinol Diabetes; 1998 Dec; 106(5):435-9. PubMed ID: 9831312
    [Abstract] [Full Text] [Related]

  • 13. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.
    Hugues JN, Cédrin-Durnerin I, Avril C, Bulwa S, Hervé F, Uzan M.
    Hum Reprod; 1996 Dec; 11(12):2581-4. PubMed ID: 9021354
    [Abstract] [Full Text] [Related]

  • 14. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
    Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, Mantalenakis S.
    Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
    [Abstract] [Full Text] [Related]

  • 15. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
    Balasch J, Fábregues F, Creus M, Puerto B, Peñarrubia J, Vanrell JA.
    Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212
    [Abstract] [Full Text] [Related]

  • 16. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D, Vandekerckhove P, Hughes E, Arnot M, Lilford R.
    Cochrane Database Syst Rev; 2000 Apr; (4):CD000410. PubMed ID: 11034687
    [Abstract] [Full Text] [Related]

  • 17. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.
    Revelli A, Poso F, Gennarelli G, Moffa F, Grassi G, Massobrio M.
    Reprod Biol Endocrinol; 2006 Jul 18; 4():38. PubMed ID: 16848893
    [Abstract] [Full Text] [Related]

  • 18. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
    Chen W, Zhang Y, Dai Q.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct 18; 35(10):588-90. PubMed ID: 11372406
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.
    Balasch J, Fábregues F, Creus M, Casamitjana R, Puerto B, Vanrell JA.
    J Assist Reprod Genet; 2000 Nov 18; 17(10):561-5. PubMed ID: 11209536
    [Abstract] [Full Text] [Related]

  • 20. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z.
    Hum Reprod; 1997 Nov 18; 12(11):2359-65. PubMed ID: 9436663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.